Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation

References

• Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Brit J Pharmacol 2006; 147(Suppl 1): S193–201
   Google Scholar
• Walter U, Gambaryan S. Roles of cGMP/cGMP-dependent protein kinase in platelet activation. Blood 2004; 104: 2609
   Google Scholar
• Hofmann F. The biology of cyclic GMP-dependent protein kinases. J Biol Chem 2005; 280: 1–4
   PubMed Web of Science ®Google Scholar
• Friebe A, Koesling D. The function of NO-sensitive guanylyl cyclase: What we can learn from genetic mouse models. Nitric Oxide 2009; 21: 149–56
   Google Scholar
• Garthwaite J. New insight into the functioning of nitric oxide-receptive guanylyl cyclase: Physiological and pharmacological implications. Mol Cell Biochem 2010; 334: 221–32
   PubMed Web of Science ®Google Scholar
• Massberg S, Sausbier M, Klatt P, Bauer M, Pfeifer A, Siess W, et al. Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′,5′-monophosphate kinase I. J Exp Med 1999; 189: 1255–1264
   PubMed Web of Science ®Google Scholar
• Hofmann F, Feil R, Kleppisch T, Schlossmann J. Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 2006; 86: 1–23
   PubMed Web of Science ®Google Scholar
• Dangel O, Mergia E, Karlisch K, Groneberg D, Koesling D, Friebe A. NO-sensitive guanylyl cyclase is the only NO receptor mediating platelet inhibition. J Thromb Haemost 2010; 8: 1343–1352
   PubMed Web of Science ®Google Scholar
• Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62: 1153–1161
   PubMed Web of Science ®Google Scholar
• Walter U, Gambaryan S. cGMP and cGMP-dependent protein kinase in platelets and blood cells. Handbook Exp Pharmacol 2009; 191: 533–548
   PubMedGoogle Scholar
• Schlossmann J, Ammendola A, Ashman K, Zong X, Huber A, Neubauer G, et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 2000; 404: 197–201
   PubMed Web of Science ®Google Scholar
• Cifuni SM, Wagner DD, Bergmeier W. CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood 2008; 112: 1696–1703
   PubMed Web of Science ®Google Scholar
• Shirakawa R, Yoshioka A, Horiuchi H, Nishioka H, Tabuchi A, Kita T. Small GTPase Rab4 regulates Ca2+-induced alpha-granule secretion in platelets. J Biol Chem 2000; 275: 33844–33849
   PubMed Web of Science ®Google Scholar
• Tolmachova T, Abrink M, Futter CE, Authi KS, Seabra MC. Rab27b regulates number and secretion of platelet dense granules. Proc Nat Acad Sci USA 2007; 104: 5872–5877
   PubMed Web of Science ®Google Scholar
• Desch M, Sigl K, Hieke B, Salb K, Kees F, Bernhard D, et al. IRAG determines nitric oxide- and atrial natriuretic peptide-mediated smooth muscle relaxation. Cardiovasc Res 2010; 86: 496–505
   Google Scholar
• Geiselhoringer A, Gaisa M, Hofmann F, Schlossmann J. Distribution of IRAG and cGKI-isoforms in murine tissues. FEBS Letters 2004; 575: 19–22
   Google Scholar
• Antl M, von Bruhl ML, Eiglsperger C, Werner M, Konrad I, Kocher T, et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 2007; 109: 552–559
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Schulte V, Brockhoff G, Bier U, Zirngibl H, Nieswandt B. Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody. Cytometry 2002; 48: 80–86
   PubMedGoogle Scholar
• Crittenden JR, Bergmeier W, Zhang Y, Piffath CL, Liang Y, Wagner DD, et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004; 10: 982–986
   PubMed Web of Science ®Google Scholar
• Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994; 216: 444–50
   PubMed Web of Science ®Google Scholar
• Fung CY, Brearley CA, Farndale RW, Mahaut-Smith MP. A major role for P2X1 receptors in the early collagen-evoked intracellular Ca2+ responses of human platelets. Thromb Haemostasis 2005; 94: 37–40
   PubMedGoogle Scholar
• Rendu F, Brohard-Bohn B. The platelet release reaction: Granules’ constituents, secretion and functions. Platelets 2001; 12: 261–273
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: The molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemostasis 2001; 86: 214–221
   PubMed Web of Science ®Google Scholar
• Kahner BN, Shankar H, Murugappan S, Prasad GL, Kunapuli SP. Nucleotide receptor signaling in platelets. J Thromb Haemost 2006; 4: 2317–2326
   PubMed Web of Science ®Google Scholar
• Strehl A, Munnix IC, Kuijpers MJ, van der Meijden PE, Cosemans JM, Feijge MA, et al. Dual role of platelet protein kinase C in thrombus formation: Staimulation of pro-aggregatory and suppression of procoagulant activity in platelets. J Biol Chem 2007; 282: 7046–7055
   Google Scholar
• Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006; 99: 1293–1304
   PubMed Web of Science ®Google Scholar
• Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005; 115: 3363–3369
   PubMed Web of Science ®Google Scholar
• Aszodi A, Pfeifer A, Ahmad M, Glauner M, Zhou XH, Ny L, et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 1999; 18: 37–48
   PubMed Web of Science ®Google Scholar
• Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, Geiger J, et al. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Nat Acad Sci USA 1999; 96: 8120–8125
   PubMed Web of Science ®Google Scholar
• Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010; 42: 608–613
   PubMed Web of Science ®Google Scholar
• Rajendran S, Chirkov YY. Platelet hyperaggregability: Impaired responsiveness to nitric oxide (“platelet NO resistance”) as a therapeutic target. Cardiovascular Drugs and Therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy 2008; 22: 193–203
   Google Scholar
• Ozuyaman B, Godecke A, Kusters S, Kirchhoff E, Scharf RE, Schrader J. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation. Thrombosis Haemostasis 2005; 93: 1161–1167
   PubMed Web of Science ®Google Scholar
• Reid HM, Kinsella BT. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitization. Independent modulation of Tp alpha signaling by nitric oxide and prostacyclin. J Biol Chem 2003; 278: 51190–51202
   Google Scholar
• Wang GR, Zhu Y, Halushka PV, Lincoln TM, Mendelsohn ME. Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Nat Acad Sci USA 1998; 95: 4888–4893
   PubMed Web of Science ®Google Scholar
• Slotta JE, Braun OO, Menger MD, Thorlacius H. Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162. Platelets 2009; 20: 505–512
   PubMed Web of Science ®Google Scholar
• Fung CY, Cendana C, Farndale RW, Mahaut-Smith MP. Primary and secondary agonists can use P2X(1) receptors as a major pathway to increase intracellular Ca(2+) in the human platelet. J Thromb Haemost 2007; 5: 910–917
   PubMed Web of Science ®Google Scholar
• Galan AM, Lopez-Vilchez I, Diaz-Ricart M, Navalon F, Gomez E, Gasto C, et al. Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thrombosis Haemostasis 2009; 102: 511–519
   PubMed Web of Science ®Google Scholar
• Hoffmeister M, Riha P, Neumuller O, Danielewski O, Schultess J, Smolenski AP. Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets. J Biol Chem 2008; 283: 2297–2306
   PubMed Web of Science ®Google Scholar